TADAIR

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

TADALAFIL

متاح من:

UNIPHARM LTD, ISRAEL

ATC رمز:

G04BE08

الشكل الصيدلاني:

FILM COATED TABLETS

تركيب:

TADALAFIL 20 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

المجال العلاجي:

TADALAFIL

الخصائص العلاجية:

Tadair is indicated in adults for the treatment of pulmonary arterial hypertension (PAH) classified as WHO functional class II and III, to improve exercise capacity. Efficacy has been shown in idiopathic PAH (IPAH) and in PAH related to collagen vascular disease.

تاريخ الترخيص:

2017-02-08

نشرة المعلومات

118898011
0217A
PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS' REGULATIONS
(PREPARATIONS) - 1986
The medicine is dispensed
with a doctor's prescription only
TADAIR
Tablets
COMPOSITION:
Each TADAIR tablet contains:
Tadalafil 20 mg
For a list of the inactive ingredients, please
see section 6: “Further Information”.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY
BEFORE USING THE MEDICINE. This leaflet
contains concise information about the
medicine. If you have further questions,
refer to the doctor or pharmacist.
This medicine has been prescribed to treat
you. Do not pass it on to others. It may
harm them even if it seems to you that their
medical condition is similar.
The preparation is not intended for the
treatment of children and adolescents
under the age of 18.
IMPORTANT INFORMATION REGARDING TADAIR:
∙ TADAIR may cause a sudden drop in
blood pressure when taken with nitrates.
Consult with the doctor or pharmacist if
you are unsure whether your prescribed
medicines have nitrates in them.
∙ A person who is taking TADAIR and
requires urgent medical care because of
heart problems, must inform the medical
team that he is taking this medicine in
order to avoid a situation in which he will
be treated with nitrates!
1. WHAT IS THE MEDICINE INTENDED
FOR?
TADAIR is intended for the treatment of
pulmonary hypertension in adults.
THERAPEUTIC GROUP:
TADAIR belongs to a group of preparations
called phosphodiesterase type 5 (PDE5)
inhibitors. These medicines work by
relaxing the blood vessels in the lungs, thus
improving the flow of blood in the lungs.
This results in an improved ability to do
physical activity.
2. BEFORE USING THE MEDICINE DO NOT USE THE PREPARATION IF:
- You are sensitive to tadalafil or any of
the inactive ingredients contained in
the medicine (see section 6: “Further
information”).
- You are taking nitrate preparations such
as amyl nitrite for the treatment of chest
pain.
- TADAIR may increase the effect of these
medicines. If you are taking any nitrate-
containing preparation or are